Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -15.54% is 54% above its 5-year average of -34.12%, near the high end of its 5-year range (-82.02%–-15.54%).
As of the fiscal period ended Tuesday, June 30, 2026. 29.77% above its 12-month average of -22.12%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -15.54%.
RETURN ON INVESTED CAPITAL (ROIC)
-15.54%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-22.12%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-22.82%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-34.12%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-34.23%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+29.77%
CURRENT VS 3Y AVG
+31.90%
CURRENT VS 5Y AVG
+54.46%
CURRENT VS 10Y AVG
+54.61%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.39%
median of 732 covered companies
CURRENT VS SECTOR MEDIAN
+53.46%
vs the sector median at left
Evolus, Inc.
Market Cap
$495.50M
Return on Invested Capital (ROIC)
-15.54%
TTM Avg
-22.12%
3Y Avg
-22.82%
5Y Avg
-34.12%
Market Cap
$496.23M
Return on Invested Capital (ROIC)
-39.63%
TTM Avg
-67.88%
3Y Avg
-87.45%
5Y Avg
-79.46%
Market Cap
$501.13M
Return on Invested Capital (ROIC)
-34.79%
TTM Avg
-53.61%
3Y Avg
-51.25%
5Y Avg
-40.96%
Market Cap
$486.60M
Return on Invested Capital (ROIC)
18.26%
TTM Avg
19.81%
3Y Avg
16.87%
5Y Avg
7.92%
Market Cap
$507.72M
Return on Invested Capital (ROIC)
-18.90%
TTM Avg
-35.16%
3Y Avg
-27.40%
5Y Avg
-20.34%
Market Cap
$479.72M
Return on Invested Capital (ROIC)
-2.19%
TTM Avg
-24.50%
3Y Avg
-28.59%
5Y Avg
-24.45%
Market Cap
$513.04M
Return on Invested Capital (ROIC)
-102.59%
TTM Avg
-133.31%
3Y Avg
-119.78%
5Y Avg
-99.25%
Market Cap
$474.59M
Return on Invested Capital (ROIC)
-1.08%
TTM Avg
-7.18%
3Y Avg
-14.01%
5Y Avg
-19.76%
Market Cap
$517.30M
Return on Invested Capital (ROIC)
-19.47%
TTM Avg
-57.88%
3Y Avg
-52.57%
5Y Avg
-47.02%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Evolus, Inc. (EOLS) | $495.50M | -15.54% | -22.12% | -22.82% | -34.12% |
| Oculis Holding AG (OCS)vs › | $496.23M | -39.63% | -67.88% | -87.45% | -79.46% |
| Allogene Therapeutics, Inc. (ALLO)vs › | $501.13M | -34.79% | -53.61% | -51.25% | -40.96% |
| Puma Biotechnology, Inc. (PBYI)vs › | $486.60M | 18.26% | 19.81% | 16.87% | 7.92% |
| 908 Devices Inc. (MASS)vs › | $507.72M | -18.90% | -35.16% | -27.40% | -20.34% |
| Arvinas, Inc. (ARVN)vs › | $479.72M | -2.19% | -24.50% | -28.59% | -24.45% |
| Crescent Biopharma, Inc. (CBIO)vs › | $513.04M | -102.59% | -133.31% | -119.78% | -99.25% |
| Cerus Corporation (CERS)vs › | $474.59M | -1.08% | -7.18% | -14.01% | -19.76% |
| Altimmune, Inc. (ALT)vs › | $517.30M | -19.47% | -57.88% | -52.57% | -47.02% |
| Contineum Therapeutics, Inc. (CTNM)vs › | $473.46M | -27.22% | -25.30% | -27.88% | -30.72% |
ROIC
-15.5%
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -15.54% |
| 2026-03-31 | -18.91% |
| 2025-12-31 | -24.69% |
| 2025-09-30 | -25.33% |
| 2025-06-30 | -26.15% |
| 2025-03-31 | -25.88% |
| 2024-12-31 | -20.29% |
| 2024-09-30 | -24.13% |
| 2024-06-30 | -21.54% |
| 2024-03-31 | -25.71% |
| 2023-12-31 | -34.99% |
| 2023-09-30 | -42.90% |
| 2023-06-30 | -43.63% |
| 2023-03-31 | -51.79% |
| 2022-12-31 | -49.69% |
| 2022-09-30 | -51.41% |
| 2022-06-30 | -46.39% |
| 2022-03-31 | -37.72% |
| 2021-12-31 | -22.22% |
| 2021-09-30 | -82.02% |
| 2021-06-30 | -73.46% |
| 2021-03-31 | -140.30% |
| 2020-12-31 | -130.88% |
| 2020-09-30 | -33.67% |
| 2020-06-30 | -46.99% |
| 2020-03-31 | -54.70% |
| 2019-12-31 | -47.58% |
| 2019-09-30 | -63.13% |
| 2019-06-30 | -47.45% |
| 2019-03-31 | -30.90% |
| 2018-12-31 | -27.70% |
| 2018-09-30 | -20.51% |
| 2018-06-30 | -23.36% |
| 2018-03-31 | -11.15% |
| 2017-12-31 | -7.78% |
| 2017-09-30 | -16.16% |
| 2017-06-30 | -9.71% |
| 2016-12-31 | -27.00% |
